VAXY
ActiveSummary
VAXY has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€48,720) and a net result of €14,244. Equity is growing by about 12% per year across the filed financial years. Its solvency ranks better than 8% of 5,756 sector peers (NACE 68, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
History
Acts, filings and financial milestones
05-01
Gazette deed
Purpose · Resignations & appointmentsResignations: STEURS Nathalie (director) and HENRY Philippe (director) · Reappointments: STEURS Nathalie (director) and HENRY Philippe (director) · Appointment: HENRY Philippe (managing director)14 facts ▸
- General meeting, 30-11-2023
- Incorporation, 11-12-2003
- Other provision, “rapport de l’organe de gestion justifiant la modification proposée à l'objet social, président” (deed in French)
- Purpose change
- Amendment of the articles (2 times)
- Capital, €61,500
- Director resignation, STEURS Nathalie (director)
- Director resignation, HENRY Philippe (director)
- Director reappointment, STEURS Nathalie (director (not named in the articles))
- Director reappointment, HENRY Philippe (director (not named in the articles))
- Other provision, “exécution mandat, décharge administrateurs démissionnaires” (deed in French)
- Registered office clause, “Uccle (1180 Bruxelles),370 avenue Brugmann (2ème étage bureau côté jardin)” (deed in French)
- +2 further facts in this act
About the unread acts
Of the 3 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.